Citation data

OpenAlex

Works that cite this article, indexed by OpenAlex.

21 resultsUpdated October 25, 2026
1

Potential value and impact of data mining and machine learning in clinical diagnostics

Critical Reviews in Clinical Laboratory Sciences 58(4) (2021)

Maryam Saberi‐Karimian; Zahra Khorasanchi; Hamideh Ghazizadeh; Maryam Tayefi; Sara Saffar Soflaei; Gordon A. Ferns; Majid Ghayour‐Mobarhan

2

Integrative role of vitamin D related and Interleukin-28B genes polymorphism in predicting treatment outcomes of Chronic Hepatitis C

BMC Gastroenterology 16(1) (2016)

Marwa O. El-Derany; Nadia Μ. Hamdy; Nadia L. Al-Ansari; Hala Osman EL-Mesallamy

3

Sustained virological response and its treatment predictors in hepatitis C virus genotype 4 compared to genotypes 1, 2, and 3: a meta-analysis

BMJ Open Gastroenterology 2(1) (2015)

Brittany E. Yee; Nghia H. Nguyen; Bing Zhang; Derek Lin; Philip Vutien; Carrie R. Wong; Glen A. Lutchman; Mindie H. Nguyen

4

Pretreatment Predictors of Response to PegIFN-RBV Therapy in Egyptian Patients with HCV Genotype 4

PLoS ONE 11(4) (2016)

Hanan H. Rizk; Nadia Μ. Hamdy; Nadia L. Al-Ansari; Hala Osman EL-Mesallamy

5

Polymorphisms at IL28B gene as predictors of viral relapse in genotype 4 Egyptian hepatitis C patients

Journal of Medical Virology 88(3) (2015)

Mona Esmail; Noha A. Hassuna; Khalda Said Amr; Eman Ramadan Ghazawy; Mohamed Abdel‐Hamid

6

Factors related to fatalities and clinical progression of Crimean-Congo hemorrhagic fever patients and the effects of IL 28-B gene polymorphism

Archives of Virology 164(2) (2018)

Feyza Yıldız Aytekin; Şener Barut; Aydın Rüstemoğlu; Ayfer Atay; Özgür Günal; Fazılet Duygu

7

Meta-analysis

European Journal of Gastroenterology & Hepatology 26(11) (2014)

Brittany E. Yee; Nghia H. Nguyen; Bing Zhang; Philip Vutien; Carrie R. Wong; Glen A. Lutchman; Mindie H. Nguyen

8

Interleukin 28B Polymorphism as a Predictor of Response to Treatment of Egyptian HCV Patients Working in Nuclear Material Authority

The Egyptian Journal of Hospital Medicine 77(1) (2019)

Hisham El-Sayed Zidan; Randa Mohamed Talaat; Amal A. A. Ammar; Moustafa Sakr

9

Role of IL-28B polymorphisms in virologic response to combined pegylated interferon and ribavirin therapy in genotype 4 chronic HCV infected patients with and without cirrhosis

Alexandria Journal of Medicine 51(3) (2014)

Amira Youssef Shaala; Mona Morsi; Reem Abdel Hameed Harfoush; Ehab Hassan ElKhouly; Mohamed Abdel Rahman Ahmed; Mohamed Nabil Roshdy

10

Is rs8099917 Polymorphism of IL-28B Gene a Good Predictor of Response to Therapy of HCV than rs12979860? An Egyptian Study

Cell Biochemistry and Biophysics 71(1) (2014)

Olfat Gamil Shaker; Amal Rashad; Ghada Abd El Aziz; Maissa El Raziky

11

Value of IFNL3 genetic polymorphism in the prediction of HCV treatment response to direct-acting antiviral drugs versus interferon therapy

Expert Review of Anti-infective Therapy 18(9) (2020)

Samar Ebrahim Ghanem; Maha Elsabaawy; Nashwa Shebl; Eman Abdelsameea; Warda Othman; Fathia Elbassal; Gamalat A. Elgedawy; Dalia M. Elsabaawy; Marwa Helal

12

Performance Evaluation of Decision Tree Classifiers for the Prediction of Response to treatment of Hepatitis C Patients

International Conference on Pervasive Computing Technologies for Healthcare (2014)

Abubakr Awad; Mahasen Mabrouk; Awad Tahany; Naglaa Ali Zayed; Sherif Mousa; Mohamed Saeed

14

Association between interleukin 28B polymorphism and sustained virological response to sofosbuvir plus daclatasvir in chronic hepatitis C genotype 4 Egyptian patients

Journal of Clinical Pharmacy and Therapeutics 46(4) (2021)

Khalid S. Hassanien; El-Sayed Mohamed El-Sayed; Raed Shahat Ismail; Zakarya Mohamed Zakarya; Gouda Kamel Helal

15

The role of hepatic progenitor cells in predicting response to therapy in Egyptian patients with chronic hepatitis C, genotype 4

African Health Sciences 19(1) (2019)

Thanaa Helal; Nehal Ahmed Radwan; Heba Mahmoud; Ahmed Medhat Zaki; Naglaa Samier Ahmed; Ali A Wahib; Ahmed Aref